Marcus Saarinen

Artiklar

Journal article: BIORXIV. 2023;:2023.11.22.568247

Expanding the GPCR-RAMP interactome.

Kotliar IB; Bendes A; Dahl L; Chen Y; Saarinen M; Ceraudo E; Dodig-Crnković T; Uhle'n M; Svenningsson P; Schwenk JM; Sakmar TP
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2023;26(9):599-606

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics.

Ågren R; Betari N; Saarinen M; Zeberg H; Svenningsson P; Sahlholm K
Article: NEUROPSYCHOPHARMACOLOGY. 2022;47(13):2319-2329

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-383856.

Saarinen M; Mantas I; Flais I; Ågren R; Sahlholm K; Millan MJ; Svenningsson P
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(23):12859

GM1 Is Cytoprotective in GPR37-Expressing Cells and Downregulates Signaling.

Hertz E; Saarinen M; Svenningsson P
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2018;61(12):5269-5278

Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson's Disease.

Jaiteh M; Zeifman A; Saarinen M; Svenningsson P; Bréa J; Loza MI; Carlsson J

Corrigendum: NEUROPSYCHOPHARMACOLOGY. 2023;48(5):846

Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP- 363856.

Saarinen M; Mantas I; Flais I; Ågren R; Sahlholm K; Millan MJ; Svenningsson P
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2023;48:391

Pharmacological Characterization of Potent Human Trace Amine-Associated Receptor 1 (TAAR1) Agonists

Saarinen M; Diaz A; Agren R; Betari N; Zeberg H; Sahlholm K; Carlsson J; Svenningsson P
Review: MOLECULAR PSYCHIATRY. 2022;27(1):534-558

Update on GPCR-based targets for the development of novel antidepressants.

Mantas I; Saarinen M; Xu Z-QD; Svenningsson P
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2022;47:391

TAAR1 Dependent and Independent Actions of the Potential Antipsychotic and Dual TAAR1/5HT1A Receptor Agonist SEP-383856

Svenningson P; Saarinen M; Mantas I; Flais I; Agren R; Sahlholm K; Millan MJ